SARS-CoV-2-IN-31

SARS-CoV-2-IN-31

• CAS Number: 1017691-52-9
• UNSPSC Description: SARS-CoV-2-IN-31 is an effective COVID-19 inhibitor. SARS-CoV-2-IN-31 exhibits excellent to mild activity against various cancer cell lines with IC50 values range from 28.84 to 38.36 μM. SARS-CoV-2-IN-31 can be used for the research of cancer[1].
• Target Antigen: SARS-CoV
• Type: Reference compound
• Related Pathways: Anti-infection
• Applications: Cancer-programmed cell death
• Field of Research: Cancer
• Assay Protocol: https://www.medchemexpress.com/sars-cov-2-in-31.html
• Solubility: 10 mM in DMSO
• Smiles: OC1=C(C(C2=C(N(C3=CC=CC=C3)N=C2C)O)C4=CC=C(CC)C=C4)C(C)=NN1C5=CC=CC=C5
• Molecular Weight: 464.56
• References & Citations: [1]Anamika Gupta, et al. Visible Light-Promoted Green and Sustainable Approach for One-Pot Synthesis of 4,4’-(Arylmethylene)bis(1H-pyrazol-5-ols), In Vitro Anticancer Activity, and Molecular Docking with Covid-19 Mpro. ACS Omega 2022.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported